Nitrase Therapeutics
The NITROME platform allows us to elucidate the biology of nitrases and delivers novel therapeutics for a wide variety of diseases.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| N/A | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
$7.0m | Series A | ||
| Total Funding | 000k | ||
Related Content
Nitrase Therapeutics is a pioneering biotechnology company that focuses on the discovery and development of novel therapeutics based on nitrase biology. Utilizing its proprietary NITROME Platform, the company leverages its unique knowledge of protein nitration to identify new nitrases, their nitro substrates, and their roles in various diseases. This platform enables the elucidation of nitrase biology, leading to the creation of innovative treatments for a broad spectrum of diseases.
Nitrase Therapeutics primarily serves the pharmaceutical and healthcare sectors, targeting unmet medical needs through its cutting-edge research and development. The company operates in the biotechnology market, which is characterized by high innovation and significant investment in R&D. Its business model revolves around the development and commercialization of nitrase-based drugs, generating revenue through partnerships, licensing agreements, and eventual product sales.
Key clients include pharmaceutical companies, research institutions, and healthcare providers looking for advanced therapeutic solutions. By focusing on the biology of nitrases, Nitrase Therapeutics aims to unlock new pathways for treating diseases that currently lack effective treatments.
Keywords: Nitrase, therapeutics, biotechnology, protein nitration, NITROME Platform, drug development, pharmaceutical, healthcare, enzyme biology, innovative treatments.